Benefit from jejunal levodopa in a patient with apomorphine pump

Journal of Neurology

Volumn 258, Issue 2, 2011, Pages 311-312

  Klostermann, Fabian ^a   Jugel, Constanze ^a   Marzinzik, Frank ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; APO GO; APOMORPHINE; BENSERAZIDE; CARBIDOPA PLUS LEVODOPA; ENTACAPONE; LEVODOPA; PRAMIPEXOLE; SELEGILINE; UNCLASSIFIED DRUG;

ADULT; AKINESIA; BRAIN ABSCESS; BRAIN DEPTH STIMULATION; CASE REPORT; CONVALESCENCE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSKINESIA; DYSTONIA; ELECTRODE; HUMAN; HYPOKINESIA; INFUSION PUMP; JEJUNUM; LETTER; MALE; MONOTHERAPY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SKIN NODULE; SUBTHALAMUS; UNIFIED PARKINSON DISEASE RATING SCALE;

ANTIPARKINSON AGENTS; APOMORPHINE; HUMANS; INFUSION PUMPS, IMPLANTABLE; JEJUNUM; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 79953798148     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-010-5698-x     Document Type: Letter

References (7)

1. Shoulson I, Glaubiger GA, Chase TN (1975) On-off response. Clinical and biochemical correlations during oral and intravenous levodopa administration in parkinsonian patients. Neurology 25:1144-1148
2. Nyholm D, Nilsson Remahl AI et al (2005) Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease. Neurology 64:216-223
3. Nyholm D, Constantinescu R, Holmberg B, Dizdar N, Askmark H (2009) Comparison of apomorphine and levodopa infusions in four patients with Parkinson's disease with symptom fluctuations. Acta Neurol Scand 119:345-348
4. Honig H, Antonini A, Martinez-Martin P, Forgacs I, Faye GC, Fox T, Fox K, Mancini F, Canesi M, Odin P, Chaudhuri KR (2009) Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life. Mov Disord 24:1468-1474
5. Odin P, Wolters E, Antonini A (2008) Continuous dopaminergic stimulation achieved by duodenal levodopa infusion. Neurol Sci 29(Suppl 5):S387-S388
6. Antonini A, Isaias IU, Canesi M, Zibetti M, Mancini F, Manfredi L, Dal Fante M, Lopiano L, Pezzoli G (2007) Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome. Mov Disord 22:1145-1149 (Pubitemid 47067225)
7. Devos D (2009) Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease. Mov Disord 24:993-1000